ArticleRisk management and healthcare policy2026
Chronic Kidney Disease Burden Attributable to Metabolic Risks Among Women Aged ≥55 Years Worldwide, 1990-2021: A Global Burden of Disease Study 2021 Analysis.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease (CKD) attributable to metabolic risks imposes a growing burden among older women, but comprehensive global assessments specifically focused on women aged ≥55 years remain limited. Methods: Using Global Burden of Disease Study 2021 data, we assessed deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), and age-standardized rates of CKD attributable to metabolic risks among women aged ≥55 years in 204 countries and territories from 1990 to 2021. We evaluated temporal and geographic patterns, compared burden across five sociodemographic index (SDI) groups, assessed SDI-related inequalities, and projected burden to 2040. For risk-specific analyses, the contributions of high fasting plasma glucose, high systolic blood pressure, and high body-mass index were compared. Results: In 2021, CKD attributable to metabolic risks caused 624,793 deaths and 13.65 million DALYs among women aged ≥55 years. The age-standardized mortality rate and age-standardized DALY rate were 78.51 and 1,725.67 per 100,000 population, respectively, and both increased over time. High fasting plasma glucose was the leading metabolic risk, whereas the burden attributable to high body-mass index increased most rapidly. Substantial regional and national heterogeneity was observed, and the burden was generally higher in lower-SDI settings. Projections indicated that the age-standardized DALY rate and total DALYs may continue to increase through 2040. Conclusion: The global CKD burden attributable to metabolic risks among women aged ≥55 years has increased and remains unevenly distributed across socioeconomic settings. Strengthening integrated management of modifiable metabolic risks, early CKD detection, and health-system capacity in resource-limited settings may help reduce this burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.